Cardica receives CE Mark for anastomosis system
Shares of Cardica, Inc. (Nasdaq: CRDC) jumped ahead of the opening bell in after the manufacturer of automated anastomosis systems for coronary artery bypass graft surgery reported that it has received European CE Mark (Conformite Europeenne) approval for its the C-Port Flex A Anastomosis System.
The C-Port Flex A system is a variation of the company’s C-Port xA Distal Anastomosis System product line and assists with the automated anastomosis, or attachment of blood vessels and grafts, during less invasive coronary artery bypass graft procedures.
Shares of Cardica rose $1.19, or 13.77%, to $9.83 in pre-market trading.
